Claudin18.2 是肿瘤靶向免疫治疗的新型分子生物标志物
Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy.
62.5分
★★★☆☆
ALL SOURCES
Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy.
Applications of mRNA Delivery in Cancer Immunotherapy.
癌症治疗不断进步,免疫治疗作为一种标准模式日益突出,已显著改善多种恶性肿瘤的治疗。
Cardiac Toxicity Associated with Cancer Immunotherapy and Biological Drugs.
肿瘤免疫治疗对改善肿瘤患者的预后有显著贡献。
共 3 条
MEMBER ACCOUNT
登录成功会直接打开下一页。